Financials · Diversified Banks · US stock · price as of 22 Oct 2026
Key indicators
Price
$336.54
52-week range
$279.10 – $366.50
Market cap
$906.7B
P/E (trailing)
14.2×
Dividend yield
1.8%
Revenue (last 12 months)
$183.1B
Revenue growth (3y a year)
12.3%
Price / book
2.4×
Return on equity
17.4%
Fair value
Fair value (average of valid models)$314.25 middle half of models $278 – $338
Versus priceFair−7% to fair value
P/E multiple
$324.78
P/B multiple
$274.82
P/S multiple
$279.68
Dividend discount, stable
$377.72
Model uncertainty
Medium
X-Ray Score
49/ 100 · Medium confidence · ahead of 44% of sector peers
Valuation42
Growth50
Profitability54
Financial health48
Dividends58
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
JPMorgan Chase is one of the largest banking groups in the United States, with consumer banking, investment banking, commercial banking and asset and wealth management businesses. It earns net interest income on loans and deposits, fees for advising on deals and underwriting securities, trading revenue, and charges for managing client assets. It also runs a large credit card business, and its results are tied to interest rates and economic conditions.
Across three years the company recorded growth of 12.3% a year. Profitability shows a return on invested capital of 44%. Shareholders receive a dividend, currently yielding 1.8%.
StocksXray gives Jpmorgan Chase & Co an X-Ray Score of 49 out of 100 (medium confidence), ahead of 44% of the S&P 500 stocks in its sector. Its strongest lens is dividends (58) and its weakest is valuation (42).
Our fair value (the average of the valid models) is $314.25 (range $278.46 to $338.01). At $336.54 the stock trades 7% above that value, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.
XStocksXray
Jpmorgan Chase & Co (JPM)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$139.87
$122.19
$159.61
$230.31
$316.13
$336.54
Market cap
$423.3B
$362.9B
$469.7B
$663.1B
$879.3B
$906.7B
P/E
9.1×
10.1×
9.8×
11.7×
15.8×
14.2×
Price / book
1.4×
1.2×
1.4×
1.9×
2.4×
2.4×
Dividend yield
2.72%
3.27%
2.57%
2.08%
1.83%
1.83%
Fundamentals checklist ● 4 Good · ● 0 Average · ● 3 Bad · each check graded against the sector
Risk models
Piotroski F-Score2 of 9Bad
Growth
EPS growth (3y)18.3%Good
Revenue growth (3y)12.3%Good
Growth consistency80%Bad
Valuation
Fair value vs price0.9×Bad
Profitability
Return on invested capital44.4%Good
Operating margin45.8%Good
XStocksXray
Jpmorgan Chase & Co (JPM)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
121,649
128,695
158,104
177,556
182,447
183,077
Net income
48,300
37,700
49,600
58,500
57,000
65,019
Diluted EPS ($)
15.36
12.09
16.23
19.75
20.02
23.72
Net margin
39.7%
29.3%
31.4%
32.9%
31.2%
35.5%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
3,743,567
3,665,743
3,875,393
4,002,814
4,424,900
5,015,069
Cash
740,834
567,234
624,151
469,317
343,338
309,811
Total debt
53,594
44,027
44,712
52,893
64,776
72,430
Equity
294,127
292,332
327,878
344,758
362,438
374,598
Dividend per share ($)
3.80
4.00
4.10
4.80
5.80
6.00
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value is the average of up to 15 valuation models, most of them anchored to the company's own multiples, so it stays near the price and should be read as a range, not a point. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.
